Lobbying Filing Details

Total Spending

$780,000

Activities

6

Lobbyists

12

Gov't Entities

48

Filing Information
Filing UUID:
dc3c3a3e-6e91-4edc-932b-c468f5456bd9
Type:
Q2 - 2nd Quarter - Report
Period:
2017 - 2nd Quarter (Apr 1 - June 30)
Date Posted:
July 20, 2017 at 11:23 PM
Income:
$0
Expenses:
$780,000
Expense Method:
Method A - Reporting amounts using LDA definitions only
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Beth Anne Cole
Registrant
ASSOCIATION FOR ACCESSIBLE MEDICINES

Association representing the interests of the generic pharmaceutical industry.

Washington, District of Columbia
Client
ASSOCIATION FOR ACCESSIBLE MEDICINES
District of Columbia, United States of America
Lobbying Activities (6)
Activity 1
Budget/Appropriations

FDA Funding.
S.2956: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017.
H.R.5054: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017.
S.Con.Res.3: A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026.

Lobbyists (9)
  • HEIDI WILSON
  • MICHAEL BRZICA
  • CHRISTOPHER BOWLIN
  • JEFFREY FRANCER
  • DAVID R. GAUGH
  • JOHN BILLINGS
  • THOMAS JAMES GARRIGAN
  • ERIK C KOMENDANT
  • CHRISTIAN OMAR CRUZ
Government Entities (8)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Government Accountability Office (GAO)
  • Office of Management & Budget (OMB)
  • U.S. Trade Representative (USTR)
  • ... and 3 more
Activity 2
Copyright/Patent/Trademark

Inter Partes Review (IPR) process.
Patent Settlements.

Lobbyists (7)
  • CHRISTINE SIMMON
  • MICHAEL BRZICA
  • CHRISTOPHER BOWLIN
  • JEFFREY FRANCER
  • JOHN BILLINGS
  • ERIK C KOMENDANT
  • CHRISTIAN OMAR CRUZ
Government Entities (8)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Government Accountability Office (GAO)
  • Office of Management & Budget (OMB)
  • U.S. Trade Representative (USTR)
  • ... and 3 more
Activity 3
Medicare/Medicaid

Medicare Part D Program and Generic Drugs.
Medicare reimbursement for biosimilars.
Medicaid Rebate Penalty.
Medicare Part D Low Income Subsidy (LIS) Program.

Lobbyists (11)
  • CHRISTINE SIMMON
  • HEIDI WILSON
  • MICHAEL BRZICA
  • CHESTER DAVIS JR
  • CHRISTOPHER BOWLIN
  • DAVID R. GAUGH
  • JOHN BILLINGS
  • CRAIG BURTON
  • THOMAS JAMES GARRIGAN
  • ERIK C KOMENDANT
  • CHRISTIAN OMAR CRUZ
Government Entities (8)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Government Accountability Office (GAO)
  • Office of Management & Budget (OMB)
  • U.S. Trade Representative (USTR)
  • ... and 3 more
Activity 4
Pharmacy

Implementation of Food and Drug Administration Safety and Innovation Act (FDASIA) and Generic Drug User Fee Amendments (GDUFA).
Biosimilar User Fee Act (BsUFA).
Labeling of Generic Drugs.
Biosimilars Naming.
Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products.
Prescription Drug Costs.
H.R.2841: FAST Generics Act of 2015.
H.R.2051: FAST Generics Act of 2017.
S.124: Preserve Access to Affordable Generics Act.
H.R.1245/S.469: Affordable and Safe Prescription Drug Importation Act.
H.R.1314: Bipartisan Budget Act of 2015.
Risk Evaluation and Mitigation Strategies (REMS).
Biologic Exclusivity.
Biologics Price Competition and Innovation Act (BPCIA).
H.R.2562/S.1115: Making Pharmaceutical Markets More Competitive Act.
S.771: Improving Access To Affordable Prescription Drugs Act.
Pharmaceutical Exclusivity.
S.3056: CREATES Act of 2016.
H.R.2212/S.974: CREATES Act of 2017.
H.R.6043/S.3335: Fair Accountability and Innovative Research Drug Pricing Act of 2016.
S.297: Increasing Competition in Pharmaceuticals Act.
H.R.749: Lower Drug Costs through Competition Act.
Drug Importation.
H.R.2430/S.934: FDA Reauthorization Act of 2017.
FDA Commissioner Nomination.

Lobbyists (12)
  • CHRISTINE SIMMON
  • HEIDI WILSON
  • MICHAEL BRZICA
  • CHESTER DAVIS JR
  • CHRISTOPHER BOWLIN
  • JEFFREY FRANCER
  • DAVID R. GAUGH
  • JOHN BILLINGS
  • CRAIG BURTON
  • THOMAS JAMES GARRIGAN
  • ERIK C KOMENDANT
  • CHRISTIAN OMAR CRUZ
Government Entities (8)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Government Accountability Office (GAO)
  • Office of Management & Budget (OMB)
  • U.S. Trade Representative (USTR)
  • ... and 3 more
Activity 5
Taxation/Internal Revenue Code

Taxation Issues Related to Opioid Pharmaceuticals.
User Fee Programs.

Lobbyists (11)
  • HEIDI WILSON
  • MICHAEL BRZICA
  • CHESTER DAVIS JR
  • CHRISTOPHER BOWLIN
  • JEFFREY FRANCER
  • DAVID R. GAUGH
  • JOHN BILLINGS
  • CRAIG BURTON
  • THOMAS JAMES GARRIGAN
  • ERIK C KOMENDANT
  • CHRISTIAN OMAR CRUZ
Government Entities (8)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Government Accountability Office (GAO)
  • Office of Management & Budget (OMB)
  • U.S. Trade Representative (USTR)
  • ... and 3 more
Activity 6
Trade (domestic/foreign)

General Trade Issues.
Trans-Pacific Partnership (TPP).
Transatlantic Trade and Investment Partnership (TTIP).
Biologic Exclusivity.
USTR Confirmation.
North American Free Trade Agreement.

Lobbyists (7)
  • MICHAEL BRZICA
  • CHRISTOPHER BOWLIN
  • JEFFREY FRANCER
  • DAVID R. GAUGH
  • JOHN BILLINGS
  • ERIK C KOMENDANT
  • CHRISTIAN OMAR CRUZ
Government Entities (8)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Government Accountability Office (GAO)
  • Office of Management & Budget (OMB)
  • U.S. Trade Representative (USTR)
  • ... and 3 more

Source: LDA.gov, data retrieved November 4, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.